In a recent post on Pharmalot, the pharmaceutical industry blog highlighted a recent survey that gauged American opinions on the speed and safety of the process for developing new medicines. The survey, conducted by Eli Lilly and ResearchAmerica, measured a number of opinions Americans hold regarding the pharmaceutical industry and the FDA itself.
While over 70 per cent of the respondents trust the FDA approval process for new drugs, more than half say the process should be faster. The most stunning numbers in the survey come from the questions regarding industry collaborations with universities and the government. Ninety-four per cent of the respondents said that pharmaceutical companies, universities, and the government should work together to develop new medicines more quickly and safely, and 88 per cent said that it was a good idea for drug companies to collaborate with hospitals, universities, and other health institutions.
The Lilly/Research America survey gives even more weight, the weight of public opinion,that the pharmaceutical industry must continue to increase its collaborations with medical experts to ensure that new medicines are delivered safely and in a timely fashion. Working with the right experts at the right points of development can save millions of dollars in development costs, and, more importantly, save more lives.
At Thought Leader Select, the collaborative synergy of the pharmaceutical industry and medical experts is our business. We provide objective, validated data on key opinion leaders, including physicians, nurses, nurse practitioners, physician assistants, medical researchers, and regulatory/reimbursement specialists. We take our work seriously—our methods provide the highest levels of transparency, to ensure that companies are working with the right people for the right reasons.
Read the entire Pharmalot post here.
